Top rated healthcare market data research experts from iDataResearch.com
High quality healthcare market data research solutions by iData Research: iData Research is a full-service healthcare consulting and market research firm dedicated to the provision of business intelligence for medical device, biologics, dental, and pharmaceutical industries. For over 19 years, we have specialized in healthcare market research and consulting, building long-term relationships with key industry insiders, doctors, and specialists as well as healthcare authorities. This is so that we can provide the most relevant, accurate, and trustworthy global market insight possible. Find even more details on iData.
Marketing decisions made based on poor data is costing companies $500K to $10M in lost revenue and many people their jobs. The right data solution will define the true reality of your market and how your company can thrive within it. It helps you increase your bottom-line and facilitates your expansion and consolidation plans. When you can trust the source of your data, you can make better long-lasting and impactful decisions faster and with confidence.
Whether you are looking for an overall appreciation of certain global markets; or a deep understanding of a specific industry in a particular geography and year; or even identifying the number of surgeries/procedures performed in a country, we can provide you with the necessary information presented in various formats. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segmen ts. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment. MedCore is ideal for small to medium device companies, looking for extensive data on everything from hard-to-find and esoteric markets to established competitive areas.
Your corporate license data set will be compiled, verified and put together by a team of analysts specialized in looking at high volumes of product data. This data set will be formatted to give you filtering options on different product attributes. Through a familiar Excel format, pivot tables and pivot charts are provided to give your team quick access to the insights that you will be excited to see. This allows you to easily manipulate the data or transfer it into presentations and reports. Alternatively, you can opt for a Tableau visualization file which can also be provided (separate licensing fees apply for tableau users). MedSKU clients will also have access to the analyst team for clarification and questions regarding the data they receive, as well as feedback opportunities to improve the customization.
You will find not only revenue forecasts in the iData Pharma custom reports, but also units sold, average selling prices of each drug by geography and market shares of products and manufacturers by country or region. Our custom reports analyse and explain commercial prospects at the global, regional, national and product levels, for each topic. This will empower you to assess opportunities and commercial potentials for your related products and services.
iData medical market surveys will provide you with invaluable customer insights to guide your organization’s strategy and position it for continued success. Many of our clients have used our surveys to get a better picture of the market size, a better outlook on marketing efforts effectiveness, and to find the best ways to meet customers’ needs. Whether it is to gauge user purchasing habits, marketing penetration, or obtain statistically significant data on specific products and services, our survey team is equipped to respond to your specific requests. Market research surveys can reveal truths about the competitive landscape that might not have been obvious. For instance, they can demonstrate that a target market strategy should be revisited because too much money is being spent to pursue an unprofitable market segment.